EyeArt® News

Dr. Srinivas Sadda’s AAO 2019 Featured Presentation on EyeArt® Multi-Center, Prospective Clinical Trial Results Highlighted on AAO Website

Dr. Srinivas Sadda of Doheny Eye Institute presented new research at AAO 2019 that shows that EyeArt®, an automated, artificial intelligence (AI) screening system accurately detects diabetic retinopathy 95.5 percent of the time. The system doesn’t require the input of an expert ophthalmologist and it can provide a reading in 60 seconds, making real-time screening possible for primary care practices and diabetes centers. Accurate, automated screening is an important development for millions of patients living with diabetes who need to be screened yearly for vision-threatening diabetic retinopathy.  The study was featured on the AAO website at https://www.aao.org/newsroom/news-releases/detail/using-ai-to-screen-diabetic-eye-disease-feasible



Share This Post